7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine

C94H79BrIN25O2 — CID 158237498

IUPAC7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine
SMILESCc1cccc(-c2[nH]nc(NCCN3CCOCC3)c2-c2ccc3ncc(-c4ccncc4)cc3n2)n1.Cc1cccc(-c2[nH]ncc2-c2ccc3ncc(-c4ccncc4)cc3n2)n1.Cc1cccc(-c2n[nH]c(I)c2-c2ccc3ncc(-c4ccncc4)cc3n2)n1.Cc1cccc(-c2nn(C3CCCCO3)cc2-c2ccc3ncc(Br)cc3n2)n1
InChIInChI=1S/C28H28N8O.C22H20BrN5O.C22H15IN6.C22H16N6/c1-19-3-2-4-24(32-19)27-26(28(35-34-27)30-11-12-36-13-15-37-16-14-36)23-6-5-22-25(33-23)17-21(18-31-22)20-7-9-29-10-8-20;1-14-5-4-6-19(25-14)22-16(13-28(27-22)21-7-2-3-10-29-21)17-8-9-18-20(26-17)11-15(23)12-24-18;1-13-3-2-4-18(26-13)21-20(22(23)29-28-21)17-6-5-16-19(27-17)11-15(12-25-16)14-7-9-24-10-8-14;1-14-3-2-4-20(26-14)22-17(13-25-28-22)18-5-6-19-21(27-18)11-16(12-24-19)15-7-9-23-10-8-15/h2-10,17-18H,11-16H2,1H3,(H2,30,34,35);4-6,8-9,11-13,21H,2-3,7,10H2,1H3;2-12H,1H3,(H,28,29);2-13H,1H3,(H,25,28)
InChIKeyGFDKHUVBGGBIQX-UHFFFAOYSA-N
MW1797.65 g/mol
LogP19.03
Rot. Bonds16

About 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine

7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine (PubChem CID 158237498) has the molecular formula C94H79BrIN25O2 and a molecular weight of 1797.65 g/mol. Its IUPAC name is 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine.

Molecular Properties

Compound Name7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine
PubChem CID158237498
Molecular FormulaC94H79BrIN25O2
Molecular Weight1797.65 g/mol
Exact Mass1795.51
IUPAC Name7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine
SMILESCc1cccc(-c2[nH]nc(NCCN3CCOCC3)c2-c2ccc3ncc(-c4ccncc4)cc3n2)n1.Cc1cccc(-c2[nH]ncc2-c2ccc3ncc(-c4ccncc4)cc3n2)n1.Cc1cccc(-c2n[nH]c(I)c2-c2ccc3ncc(-c4ccncc4)cc3n2)n1.Cc1cccc(-c2nn(C3CCCCO3)cc2-c2ccc3ncc(Br)cc3n2)n1
InChIInChI=1S/C28H28N8O.C22H20BrN5O.C22H15IN6.C22H16N6/c1-19-3-2-4-24(32-19)27-26(28(35-34-27)30-11-12-36-13-15-37-16-14-36)23-6-5-22-25(33-23)17-21(18-31-22)20-7-9-29-10-8-20;1-14-5-4-6-19(25-14)22-16(13-28(27-22)21-7-2-3-10-29-21)17-8-9-18-20(26-17)11-15(23)12-24-18;1-13-3-2-4-18(26-13)21-20(22(23)29-28-21)17-6-5-16-19(27-17)11-15(12-25-16)14-7-9-24-10-8-14;1-14-3-2-4-20(26-14)22-17(13-25-28-22)18-5-6-19-21(27-18)11-16(12-24-19)15-7-9-23-10-8-15/h2-10,17-18H,11-16H2,1H3,(H2,30,34,35);4-6,8-9,11-13,21H,2-3,7,10H2,1H3;2-12H,1H3,(H,28,29);2-13H,1H3,(H,25,28)
InChIKeyGFDKHUVBGGBIQX-UHFFFAOYSA-N
XLogP19.03
TPSA330.94 Ų
H-Bond Donors4
H-Bond Acceptors24
Rotatable Bonds16
Heavy Atoms123
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001797.65
LogP ≤ 519.03
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine?
The IUPAC name of 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine (CID 158237498) is 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine.
What is the SMILES notation for 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine?
The canonical SMILES for 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine is Cc1cccc(-c2[nH]nc(NCCN3CCOCC3)c2-c2ccc3ncc(-c4ccncc4)cc3n2)n1.Cc1cccc(-c2[nH]ncc2-c2ccc3ncc(-c4ccncc4)cc3n2)n1.Cc1cccc(-c2n[nH]c(I)c2-c2ccc3ncc(-c4ccncc4)cc3n2)n1.Cc1cccc(-c2nn(C3CCCCO3)cc2-c2ccc3ncc(Br)cc3n2)n1.
What is the InChIKey of 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine?
The InChIKey is GFDKHUVBGGBIQX-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H28N8O.C22H20BrN5O.C22H15IN6.C22H16N6/c1-19-3-2-4-24(32-19)27-26(28(35-34-27)30-11-12-36-13-15-37-16-14-36)23-6-5-22-25(33-23)17-21(18-31-22)20-7-9-29-10-8-20;1-14-5-4-6-19(25-14)22-16(13-28(27-22)21-7-2-3-10-29-21)17-8-9-18-20(26-17)11-15(23)12-24-18;1-13-3-2-4-18(26-13)21-20(22(23)29-28-21)17-6-5-16-19(27-17)11-15(12-25-16)14-7-9-24-10-8-14;1-14-3-2-4-20(26-14)22-17(13-25-28-22)18-5-6-19-21(27-18)11-16(12-24-19)15-7-9-23-10-8-15/h2-10,17-18H,11-16H2,1H3,(H2,30,34,35);4-6,8-9,11-13,21H,2-3,7,10H2,1H3;2-12H,1H3,(H,28,29);2-13H,1H3,(H,25,28).
What are the key properties of 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine?
7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine has a molecular weight of 1797.65 g/mol, XLogP of 19.03, 16 rotatable bonds, 4 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 7-bromo-2-[3-(6-methyl-2-pyridinyl)-1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;2-[5-iodo-3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine;5-(6-methyl-2-pyridinyl)-N-(2-morpholin-4-ylethyl)-4-(7-pyridin-4-yl-1,5-naphthyridin-2-yl)-1H-pyrazol-3-amine;2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-7-pyridin-4-yl-1,5-naphthyridine is sourced from PubChem (CID 158237498), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).